For veterans living with chronic low back pain after failed spine surgeries, spinal fusion is often presented as the only remaining option. In many cases, it is not. Biologic disc repair using intra-annular fibrin injection may offer a minimally invasive path toward reduced pain and restored function — though candidacy and outcomes vary by individual.

Patient Overview

A retired Army Airborne Sergeant First Class presented to ValorSpine after years of debilitating low back pain. He had served 18 years, including multiple deployments with an Airborne Division. His career demanded heavy rucksack carries, sustained whole-body vibration from military vehicles, and repeated hard landings from parachute jumps — cumulative stresses that took a lasting toll on his spine.

Before his pain began dictating daily life, he was a dedicated father of two teenagers and an avid outdoorsman. His medical history included a prior L5-S1 microdiscectomy five years earlier, which provided temporary relief, and progressively worsening degenerative disc disease.

The Challenge

For this patient, the relentless low back pain was not simply a physical ailment — it was an ongoing threat to his identity and independence. After his microdiscectomy, he experienced roughly a year of improved function, but pain returned and often radiated into his left leg. On most days, he rated his pain at 8 out of 10 — a deep, aching sensation that escalated into sharp, electric pain with bending or lifting.

He could no longer hike with his family, coach his son’s soccer team, or spend a quiet afternoon fishing. Sitting for more than 15 to 20 minutes became excruciating. The emotional toll was significant, with growing frustration and a sense of isolation as he faced the prospect of a life severely limited by chronic pain.

Diagnostic imaging revealed significant degenerative disc disease at L4-L5 and a recurrent disc issue at the previously operated L5-S1 level, characterized by persistent annular tears. These tears can prevent the disc from healing naturally and allow inflammatory proteins to leak out and irritate surrounding nerves — a primary driver of chronic discogenic pain. Physicians he consulted recommended either a repeat discectomy or multi-level spinal fusion.

He had seen fellow veterans undergo fusion surgeries with limited improvement, adjacent segment disease, or significant loss of spinal mobility. He was caught between unrelenting pain and the prospect of a highly invasive, potentially irreversible surgery with no outcome guarantees.

Previous Treatments Tried

Before arriving at ValorSpine, this patient had worked through a wide range of conventional and alternative treatments. Extended physical therapy programs — focused on core strengthening, flexibility, and posture correction — provided temporary relief during acute flare-ups but did little to address the underlying structural issues.

Multiple rounds of epidural steroid injections offered some weeks of reduced inflammation, but the effects did not last. Steroid injections can reduce acute inflammation but do not repair damaged disc tissue. He also pursued chiropractic care, acupuncture, and various medications including NSAIDs and muscle relaxants — all of which managed symptoms without resolving the root cause.

The original microdiscectomy had removed a portion of the herniated disc material, but the underlying annular tear likely never fully healed, contributing to persistent discogenic pain and reherniation risk. Each treatment that did not hold reduced his optimism further and left him searching for an option that did not require irreversible surgery.

Our Approach

Our clinical team understood this patient’s apprehension about fusion and his desire to find a less invasive, more regenerative approach. Our philosophy centers on identifying the root cause of chronic discogenic pain — particularly annular tears and disc degeneration — and then supporting the body’s natural healing mechanisms where possible.

After a thorough diagnostic review, including medical history, physical examination, and advanced imaging, our team identified that his pain stemmed primarily from damaged, leaking discs — a condition known as discogenic pain. This is driven by chemical irritation from nucleus material leaking through annular tears and by mechanical instability in the affected segments. Nerve compression from the earlier discectomy had been largely addressed; the persistent discogenic component had not.

Based on this evaluation, we recommended a targeted, minimally invasive biologic disc repair using intra-annular fibrin injection. This approach is designed to seal and reinforce damaged annular tissue. Fibrin — a natural protein involved in tissue repair — is injected directly into the damaged disc, acting as a scaffold to support the body’s own healing response. By filling tears in the outer wall of the disc, the goal is to reduce inflammatory leakage, improve disc stability, and address the discogenic source of pain. Outcomes vary by individual, and candidacy is evaluated on a case-by-case basis.

Treatment Process

Following a comprehensive consultation and diagnostic review, this patient underwent the intra-annular fibrin injection procedure at ValorSpine. The procedure is minimally invasive and performed under fluoroscopic (X-ray) guidance to ensure precise fibrin delivery into the affected discs at L4-L5 and L5-S1. He received mild sedation for comfort during the procedure, which took approximately one hour. He was discharged the same day with specific post-procedure instructions.

The initial recovery period involved limited activity for several days, followed by a gradual increase in movement as tolerated. Our clinical team emphasized adherence to a structured rehabilitation protocol — including gentle walking and guided exercises — to support the healing process. Some mild soreness at the injection sites during the first week is a normal part of the healing response. Our team provided ongoing monitoring and support throughout recovery.

The Results

This patient’s recovery followed the gradual timeline that biologic disc repair often involves — meaningful improvement that built progressively over months, not days. In the first several weeks, he noticed a mild reduction in the frequency and intensity of his leg pain, suggesting that sealing the annular tears was beginning to reduce nerve irritation.

By the two-month mark, he reported a moderate improvement in overall low back pain — roughly a 50% reduction in daily pain levels, dropping from an 8 out of 10 to approximately a 4 out of 10. He could sit for longer periods without severe discomfort, and his radiating leg pain had shifted from sharp, electric pain to an occasional dull ache, primarily with overexertion.

The most significant improvements emerged between four and six months post-procedure. He reported a 70% or greater reduction in low back pain, consistently rating it at 2 to 3 out of 10. His sciatica had largely resolved. He began taking short hikes with his family — an activity he had been unable to pursue for years — and returned to coaching his son’s soccer team.

At the nine-month follow-up, he was active across most of his pre-injury activities, with continued attention to body mechanics. He was fishing again, spending hours outdoors without debilitating pain. He also avoided spinal fusion — an outcome that preserved his spinal mobility and quality of life. Results like his reflect what biologic disc repair can offer for appropriately evaluated candidates; they do not represent a guaranteed or typical outcome for any given individual.

Expert Take

Cases like this one highlight a pattern our clinical team sees with veterans presenting after failed spinal surgeries: the original procedure addressed nerve compression, but the underlying annular pathology — the leaking, structurally compromised disc — was never resolved. Intra-annular fibrin injection targets that specific gap. For candidates whose imaging and symptom profile align with discogenic pain from annular tears, this approach may offer meaningful relief without the permanence and recovery demands of fusion. Evaluation is always individualized; not each person with degenerative disc disease will be a candidate, and outcomes vary widely.

Key Takeaways

1. Accurate Diagnosis Shapes Better Outcomes: Persistent pain after a discectomy does not always mean nerve compression has returned. Identifying and treating annular tears and discogenic pain as a distinct source is important for appropriate treatment planning.
2. Fusion Is One Option, Not the Only Option: For patients with chronic low back pain from disc degeneration and annular tears who meet candidacy criteria, minimally invasive biologic disc repair may offer a viable alternative to spinal fusion.
3. Biologic Repair Supports the Body’s Own Healing: Rather than removing tissue or permanently altering spinal anatomy, this approach aims to reinforce and stabilize damaged disc structures at the annular level.
4. Veterans Face Distinct Spinal Challenges: The cumulative physical demands of military service — rucksack loading, vehicle vibration, jump impact — create disc pathology patterns that may benefit from targeted, tissue-preserving approaches.
5. Patient Commitment Matters: Adherence to post-procedure rehabilitation plays a meaningful role in outcomes. Recovery from biologic disc repair is an active process that requires patient participation.

“For years, I felt like my body was betraying me. Every doctor I saw just wanted to talk about more surgery or fusion. ValorSpine gave me a different path — one that didn’t require cutting me open. I can hike, I can coach, I can just be present with my family again. I’m grateful every day.”

— Retired Army Airborne Veteran and ValorSpine Patient

For related reading, explore what options remain after a failed discectomy, our guide on avoiding spinal fusion as a veteran, and an overview of non-surgical back pain relief options for veterans.